Skip to main content
. Author manuscript; available in PMC: 2014 Aug 1.
Published in final edited form as: Trends Cardiovasc Med. 2013 Mar 15;23(6):229–235. doi: 10.1016/j.tcm.2012.12.006

Figure 2. HDACs in ischemic heart disease.

Figure 2

Both ischemia and ischemia/reperfusion trigger cell death via mechanisms that involve class I HDACs. Inhibition of HDAC activity reduces infarct size. Post-infarct stresses induce cardiomyocyte hypertrophy, cell death (e.g. apoptosis) and fibrosis. Again, HDAC inhibitors are capable of blocking elements of these detrimental biological processes and preserve cardiac function.

HHS Vulnerability Disclosure